stock price with Mylan merger

[anonymous]

Yikes, this Mylan merger sure has not been good for the stock price.

 

[anonymous]

Yikes, this Mylan merger sure has not been good for the stock price.

Investors know Pfizer is a cash heavy sinking ship. Generics is where we need to be; we’ve got nothing else, and most of what we touch turns to crap, anyway.
Drug prices are under pressure and all of Pharma will be taking a hit.

 

[anonymous]

you don’t think all these moves (Generics, consumer) are setting Pfizer up for a huge MA play?

 

[anonymous]

So are we ending Greenstone or will it become Mylan?

 

[anonymous]

Greek financial acumen at its worst

 

[anonymous]

Greek financial acumen at its worst

PFE has never cared about the stock price. Although they want you to think that they are Shareholder oriented they are not. In 1999 when PFE purchased Warner Lambert the stock price was $50.00, over the next 10 years it fell yearly to a bottom of about $25.00. Since then it still hasn't recovered from 1999. Literally a generation of employees have not had stock appreciation. DO NOT GO ALL IN W/ THE 401K STOCK, you will be severely disappointed over your career. It's a dividend stock people, that's it.

 

[anonymous]

20s as the profitable cash cow drugs will leave Pfe and go to Mylan thus push stock down so cash in all RSU & options before August merger.

 

[anonymous]

2000

 

[anonymous]

you don’t think all these moves (Generics, consumer) are setting Pfizer up for a huge MA play?

Yeah, the M&A play will be Pfizer gets bought. The new Pfizer (growth part) will have a market cap of about 100B; which is considerably less than say BMY OR NVS... It’s going to interesting to see how this plays out over the next 3 years, but I do think we need to wrap our heads around the idea that we will become an acquirable asset in the new structure; we haven’t had to think that way for a long time.